News & Media
A3P Biomedical AB is a Swedish company with a global mission – to radically improve precision in prostate cancer diagnostics and treatment. The company’s leading product is Stockholm3, a clinically and commercially validated blood test for early detection of aggressive prostate cancer. The test is developed by researchers at Karolinska Institutet.
For more information please contact us.
Latest press release
A3P in media
Salming and Sauk about prostate cancer and the importance of taking a test
April 22, 2021
The truth about my prostate cancer
April 20, 2021